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Three driving forces call for an intensive effort focused on
cardiovascular disease (CVD) prevention: 1) the dominant
risk factors for CVD are known; 2) effective interventions
are available; 3) CVD remains the leading cause of death.
The previous four task forces have outlined the magnitude
of the CVD problem, and documented the cost-utility,
intervention efficacy, and adherence strategies available for
implementation, yet a majority of the U.S. population is not
receiving appropriate preventive care. The goal of Task
Force #5 is to evaluate the role of the cardiovascular (CV)
specialist as a leader and champion in rectifying missed
preventive opportunities. The knowledge, attitudes, and
beliefs of CV specialists toward prevention will be evaluated.
Considering the imminent predicted increase in the CVD
burden outlined in Task Force #1, it is essential that a plan
for leadership in prevention be identified.
An increase in the CVD burden is predicted because of
the aging of the population and the persistence of unhealthy
lifestyles such as smoking, overeating, and low levels of
physical activity (1). One approach to this predictable illness
is to prepare a greater capacity to deal with the illness—
analogous to preparing more ambulances to wait at the
bottom of a cliff during a stampede. Current knowledge of
interventions effective in preventing CVD, however, puts
one in a position to consider, metaphorically, building a
fence at the top of the cliff, thereby reducing the need for
ambulances. Physicians have historically been trained for the
ambulance activities and not for “fence building.” How well
are current and future physicians being trained to perform
prevention? This discussion addresses the extent of educa-
tion about preventive practices in medical school, residency,
and fellowship training. It also reviews the opinions and
perceptions of CV trainees and specialists about CVD
prevention. The barriers to and opportunities for integrating
prevention into daily specialty practice are discussed. The
need for training more preventive, academically oriented
CV specialists will be outlined.
HOW MUCH TRAINING IN PREVENTION?
How much preventive training in medical school? The
focus on prevention in national “report cards” such as the
Health Plan Employer Data Information Set from the
National Committee for Quality Assurance has increased
the attention on prevention in medical training as an
indicator of the quality of care. The Bureau of Health
Professions of the Health Resources and Services Admin-
istration (HRSA) and the Association of Teachers of
Preventive Medicine have worked to develop a set of core
competencies in preventive medicine for medical school (2).
In 1995, leaders in internal medicine, such as the Society of
General Internal Medicine, the Clerkship Directors in
Internal Medicine, and the HRSA prioritized prevention
and offered specific prevention-related learning objectives in
the new model curriculum for the medicine clerkship, which
is called the Core Medicine Clerkship Guide (3). Subse-
quent evaluation indicates that the Core Medicine Clerk-
ship Guide has been used in some form in more than 100
medical schools (4). Notably, the Association of American
Medical Colleges (AAMC) Liaison Committee on Medical
Education does not include any specific preventive educa-
tion content as criteria for medical school accreditation, and
33% of medical schools do not have preventive medicine
content as required coursework (5).
Two recent surveys of preventive training in medical
school critically review the current curriculum content in
preventive training. The Prevention Curriculum Assistance
Program (PCAP) documents that fewer than half of the
respondents were satisfied with the quality of their achieve-
ment in any of the four domains of preventive education (6).
The AAMC also performed a survey documenting that,
although preventive training was increasingly incorporated
into interdisciplinary teaching in some schools, it had been
lost during this transition in an equal number of schools (7).
The AAMC survey did note a steady increase in the
proportion of graduates reporting that an “adequate”
amount of time in the curriculum was spent on disease
prevention—from 54% in 1993 to 76% in 1997 (8). A recent
report, however, indicates that these efforts have not yet
translated into applied knowledge. Among U.S. medical
schools in 1999, the majority (69%) of graduates were not
adequately trained to treat tobacco dependence (9). Thus,
recent data imply that prevention is not adequately taught in
most medical schools.
How much training in residency? Internal medicine res-
idency programs have also developed a resource guide for
preventive training (10). The resource guide identifies a core
curriculum for training in internal medicine and includes
competency in 20 integrative disciplines, as well as 22
clinical areas. For each integrative discipline, the guide lists
a set of competencies that residents should achieve during
their training and prompts residency program directors to
decide which instructional methods and clinical settings are
best suited to accomplish each competency. There are no
available nationally representative data assessing if and how
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preventive education is being implemented in residency
training. A survey of randomly selected primary care phy-
sicians in Massachusetts performed in 1981 and 1994 did
demonstrate an overall expansion of their perceived role in
the promotion of health, although they continued to feel
inadequately trained to do so (11).
How much preventive education in fellowship training?
Because cardiologists provide most of the care for patients
with symptomatic or advanced CVD, the American College
of Cardiology (ACC) has stated that it is imperative for CV
specialists to be proficient in the primary and secondary
prevention of CVD. Indeed, since 1995, the ACC Core
Cardiology Training Symposium (COCATS) Recommen-
dations for Training in Adult Cardiovascular Medicine have
outlined preventive core components for both the faculty
and curriculum in cardiology subspecialty training. These
recommendations have recently been updated (12). Table 1
itemizes the Level 1 training, which is required for all
cardiology fellows.
The ACC Prevention of Cardiovascular Disease Com-
mittee (PCDC) conducted a survey of U.S. fellowship
training programs with regard to preventive training in
1999. Overall, 106 of 196 (54%) program responses were
received, and the results are shown in Table 2. The majority
of CV specialist training programs surveyed had both
dedicated preventive faculty and preventive/cardiac rehabil-
itation sections, but less than one-third had formal preven-
tive cardiology training as part of their program. Similarly a
recently published survey documents that only 29% of
fellowship programs had mandatory cardiac rehabilitation
rotations. This survey also documented that physicians in
programs offering at least one hour of cardiac rehabilitation
fellowship training were more likely to refer patients to
cardiac rehabilitation (13). From these survey results, it was
concluded that the majority of current CV specialist training
programs are not compliant with the ACC COCATS
Training in CV Medicine recommendations. A lack of
integration between training program certification and the
ACC COCATS recommendations, which allows noncom-
pliant clinical training programs to perpetuate inadequate
training in prevention, is also noteworthy. The failure to
provide training in cardiac rehabilitation places an addi-
tional limitation on the ability of future CV subspecialists to
function as team leaders in an increasingly multidisciplinary
healthcare system. Indeed, the current CV specialty training
has been equated to training “kings and queens” rather than
team leaders, resulting in both a lack of leadership and a lack
of appreciation of team efficacy in surmounting the com-
plexities of multifactorial risk management, which is re-
quired for prevention.
How much prevention in trainee evaluation and testing?
Evaluation often drives learning, and a large body of
evidence links the establishment of standards and assess-
ment procedures to subsequent performance. Assessment
through testing of the knowledge, skills, and attitudes of
trainees is realistically one of the few ways to make a critical
review of the outcome of instruction. In medical school,
Table 1. ACC Core Cardiology Training Symposium
(COCATS) Prevention Core Components of Cardiovascular
Medicine Training Programs
Level 1 includes training that should be part of the knowledge base of
all clinical cardiologists and includes exposure to the following general
and specific areas.
Training in these areas should ideally be undertaken in a one-month (or
longer) rotation in preventive cardiovascular medicine. An acceptable
alternative would be a one-month (or longer) rotation in a
comprehensive cardiovascular rehabilitation program that incorporates
a broad range of preventive approaches besides the traditional
rehabilitation effort focused mostly on physical exercise. While less
ideal than a block-time rotation, training in these areas could be
integrated into consultative, inpatient and outpatient rotations and
didactic components of core cardiovascular medicine programs. If the
latter approach is taken, the time allotted should be equivalent to at
least 1 month of full-time training. Training Program Directors may
also consider supplementing clinical experiences with short courses
devoted exclusively to preventive cardiology or risk factors, such as the
ACC Heart House Course in Preventive Cardiology.
General content areas:
1. Vascular biology of the heart and blood vessels
2. Clinical epidemiology and biostatistics
3. Principles of clinical trials and outcomes research
4. Principles of clinical pharmacology
Exposure to the following specific content areas is also essential:
1. Diagnosis and treatment of primary and secondary hypertension
2. Diagnosis and treatment of primary and secondary dyslipidemias
3. Diagnosis and treatment of thrombosis and hypercoagulable states
4. Management of smoking cessation and nicotine addiction
5. Cardiac rehabilitation
6. Exercise physiology
7. Nutrition and its effects on the cardiovascular system
8. Psychosocial and behavioral aspects of cardiovascular diseases
9. Diagnosis and treatment of peripheral vascular disease, including
stroke and cerebral ischemia
Adapted with permission from Beller GA, et al. ACC revised recommendations for
training in adult cardiovascular medicine core cardiology training II (COCATS II)
(Revision of the 1995 COCATS training statement). American College of Cardiol-
ogy Web site. 2002. Available at http://www.acc.org/clinical/training/cocats2.pdf.
Table 2. Prevention of Cardiovascular Disease Committee
(PCDC) Survey Results of Cardiovascular Subspecialty
Fellowship Training Programs
1. Dedicated prevention faculty:
95% had 3 to 4 dedicated preventive research faculty
95% had dedicated preventive teaching and clinical care faculty
2. Dedicated preventive cardiology section or cardiac rehabilitation
section:
55% preventive section
80% cardiac rehabilitation section
3. Formal preventive cardiology training:
31.5% regular lectures
13.5% regular rotations (range 4 h to 4 months; 50% had 1 month)
35.1% regular cardiac rehabilitation rotation
4. Outpatient clinics
22.5% regular lipid clinic
9.9% regular hypertension clinic
2.7% regular diabetes clinic
The majority of comments in the survey indicated that this preventive training was
covered “semi-formally,” “integrated into cardiac critical care-rotations,” and “covered
during clinical rotations.”
Source: American College of Cardiology Prevention of Cardiovascular Disease
Committee 2001.
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results from the PCAP indicated that the most frequently
used method of measuring student competence in preven-
tion was a written test (6). Results of this survey also
revealed that the majority (between 30% and 50%) of
respondents were interested in assistance to improve their
school’s methods of evaluating curriculum in prevention (6).
In residency and fellowship training, board certification
testing also uses written standardized testing. Currently, the
American College of Graduate Medical Examiners has no
specified amount or content areas of preventive education
assessment. The ACC PCDC recently reviewed the Amer-
ican Board of Internal Medicine (ABIM) preventive cardi-
ology content of this testing. According to the ABIM
report, an overall 7% of the questions were devoted to
prevention, and a goal of increasing this to 10% was
endorsed (J. Loscalzo, personal communication, February
23, 2001). Granted the literature-supported figure of 50%
for the CV risk reduction experienced in recent decades
being attributable to preventive efforts (including aspirin,
beta-blockers, lipid lowering, and lifestyle-related changes),
an increase in this proposed figure to at least 15% seems
quite appropriate. The new ABIM Practice Improvement
Module program, which is in development for physician
recertification, has selected preventive cardiology as one of
the first modules. Designed to assist physicians in the
self-evaluation of that knowledge and ability to implement
their knowledge, these modules will have four major com-
ponents, including: 1) chart-stimulated patient review; 2)
patient questionnaire; 3) systems questionnaire; and 4)
multiple-choice questions (14).
Barriers and templates for training improvement. There
are a number of barriers to the incorporation of compre-
hensive preventive education throughout medical training.
Limited time, lack of curriculum integration, lack of trainee
interest, and focus on crucial in-patient issues are commonly
cited barriers. American cultural beliefs that marginalize the
role of prevention and glamorize the impact of more dramatic
medical interventions also probably serve as a barrier (15).
A proposed approach to incorporating prevention into all
aspects of training is to build prevention-related objectives
into a global curricular renewal or reform process of medical
schools, residency, and fellowship programs (16). As med-
ical school and postgraduate training programs undergo
curriculum reform, core educational approaches should
include a commitment to integrate crosscutting themes,
such as prevention. Training guidelines, such as the PCAP
Core Competencies (2), the Internal medicine residency
resource guide for training in prevention (10), and the ACC
COCATS recommendations (12), should be actively incor-
porated into problem-based learning cases, interdisciplinary
conferences, and community health projects, as was done in
1999 by the University of Rochester (16). This is accom-
plished by leadership vision on the part of the dean,
department chairs and faculty. Faculty development activi-
ties such as organizational development, instructional de-
velopment and personal development, are also essential in
supporting the incorporation of preventive education. Spe-
cifically, the inadequate recognition and reward for teaching
will remain a significant impediment to substantive curric-
ular reform until direct efforts are made to acknowledge
these important contributions (17).
WHAT TYPE OF
PRACTITIONER TRAINING IS NEEDED?
Overview of CME/educational opportunities. There are
a variety of continuing medical education (CME) opportu-
nities related to CVD prevention available for practicing
physicians and provided by CME and industry-supported
education programs. The pharmaceutical industry has been
among the most persistent in encouraging physicians to
screen, evaluate, and treat CV risk factors more aggressively.
By contrast, organizations directly involved with CV train-
ing have been less aggressive. Among ACC-sponsored
educational programs from May to December of 2001, only
2 of 36 offerings appeared directly related to Preventive
Cardiology. These were entitled “Implementing Coronary
Risk Factor Modification: Why, How, and In Whom?” and
the “1st Annual Conference on the Integration of Comple-
mentary Medicine in a Traditional Cardiology Practice.”
Other programs undoubtedly contain preventive compo-
nents, but these could not be quantified. It is not known
how many formal training programs in preventive cardiol-
ogy are available for CV fellows in training.
Perceptions/opinions about CV specialists’ need for pre-
ventive education. There is little concrete information
available on the perceptions and opinions about the CV
specialist’s need for preventive education. Only rarely has a
publication addressed the training of CV specialists (18).
This lack of educational research activity data is especially
apparent when compared with other disciplines. There are a
number of studies in general and family practice, for
example, documenting attitudes toward prevention among
practicing physicians and trainees (19).
A Medline search designed to evaluate published research
on preventive education among physicians used the key
words, “Cardiovascular,” “Prevention,” “Physician” and
“Education,” and yielded 111 references in English. Only
four directly addressed prevention among CV specialists (one
of these examined the issue of antibiotic prophylaxis for
patients with valvular heart disease). Indeed, the total number
of preventive CV manuscripts written for other health care
workers equaled the number designed for cardiologists.
Cognitive training versus training in applied systems.
With rare exceptions, there is little published on techniques
used by practicing CV specialists to facilitate prevention in
their practices. The material that is available is often
anecdotal (20).
A large component of cognitive training is essential.
From the general medical education literature it is clear that
a physician’s self-perception that he or she has the knowl-
edge to effect change is required before that physician will
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attempt intervention (21). Cognitive training and particu-
larly CME alone, however, is not sufficient. Indeed, in some
physician educational studies, cognitive training alone in the
form of conferences is used as the “control” group. Com-
pared with conferences alone, conferences and quality im-
provement consultations, conferences and a coordinator in
prevention, and a combination of these interventions pro-
duced a greater improvement in physician performance in
risk-factor management (22). In the absence of data specif-
ically addressing CV specialists, it seems intuitive that both
cognitive and applied systems training are required to
prepare specialists to establish programs in prevention.
Status of the current scientific sessions with respect to
prevention. The CV prevention content of the ACC
Scientific Sessions has been surveyed for the last three years
by the ACC PCDC. Using the resource/key words (listed in
the Appendix: Resource Guide), this search demonstrated
that CV prevention content has appropriately increased
from 6.5% in March 2000 to 19.5% in March 2001,
consistent with the increased scientific interest in this field.
Barriers and templates for improving preventive training.
There is a need to clarify the role of the CVD specialist in
prevention so that specialists view this area as within their
appropriate domain. There are, by anecdotal data, knowl-
edge deficits among practicing CV specialists in how best to
manage hypertension, lipid disorders, diabetes, cigarette
smoking, lack of exercise, and obesity, and these deficits are
undoubtedly a barrier to preventive therapy. In addition,
there is often insufficient feedback within the practice
setting to provide the specialist with a scorecard for perfor-
mance. There is virtually no formal research on educational
methods for use in training CV specialists in prevention. All of
these areas should be addressed to enhance the training
available to both trainees and practitioners in CVD prevention.
HOW SHOULD PREVENTIVE SERVICES BE
INTEGRATED INTO DAILY CV SPECIALTY PRACTICE?
Successful integration of preventive services into daily CV
specialty practice requires effective discussion of four impor-
tant elements. First, the perceptions and opinions about the
role of the specialists in delivering long-term preventive
services must be addressed and clarified. Second, evidence of
current gaps and missed opportunities for identifying high-
risk individuals and delivering appropriate preventive care
for reducing the risk of fatal and non-fatal CV events must
be presented. Third, the role of medical informatics in the
dissemination of CV clinical guidelines and in facilitating
the application of guidelines in daily specialty practice must be
reviewed. Fourth, important barriers, proposed solutions, and
templates for continued improvement must be presented.
Perceptions and opinions of the specialist. When pa-
tients are referred for evaluation and treatment of acute
coronary syndromes or other acute problems, discussions
about long-term lifestyle changes for the prevention or
control of risk factors are not seen as germane to the chief
complaint. Additionally, laboratory data such as blood
cholesterol or glucose obtained at the time of the acute event
may not be considered representative of the long-term
values and, thus, can fail to elicit appropriate management.
Often, the CV specialist perceives his or her role as
addressing the chief complaint and leaving the long-term
preventive services to the referring primary care physician.
This perception seems to be supported by studies also
showing that most family physicians see their role in the
reduction and control of CVD risk factors as central (23).
Ample evidence suggests that for these and a variety of other
reasons, many patients eligible for preventive counseling do
not receive these services even when they come in contact
with physicians (24). In fact, lifestyle and other behavioral
modifications may be an important component of the
appropriate care for the acute problem. For example, weight
gain, excess salt intake, and medication non-compliance may
be the culprits underlying “resistant” hypertension. Thus, it
may be necessary to counsel patients on lifestyle changes to
control resistant hypertension (25,26). The CV specialist has a
clear mandate for addressing primary prevention and risk-
factor control in all settings of patient encounters (27).
Many CV specialists recognize that the level of reim-
bursement for the amount of time it takes to deliver
appropriate comprehensive counseling in smoking cessa-
tion, nutrition, physical activity, and other lifestyle changes
for patients and their families is inadequate. It is more
appropriate for someone other than the specialist to deliver
that care. The use of a multidisciplinary care team that
includes non-physician providers to address preventive ser-
vices and health promotion counseling is an important part
of the solution. In addition, reimbursement reform must
address the importance of preventive services as an integral
part of specialist practice. It is important to emphasize,
however, that several studies have shown that changing
reimbursement alone is not enough to improve delivery of
preventive care (28,29).
There are various ways that physicians can incorporate
prevention into their practices and be adequately compen-
sated. Physicians can use standard billing codes and proce-
dures for the evaluation and treatment of a multitude of CV
risk factors, including hypertension, diabetes, hyperlipid-
emia, nicotine addiction, and standard CV conditions.
Nurse practitioners and physician assistants can be em-
ployed to manage risk-factor programs such as lipid and
hypertension clinics, which can be billed under the appro-
priate risk-factor code. Also, CV specialists can initiate
cardiac rehabilitation programs that are a good source of
patient retention for the practice and/or hospital. Billing
codes exist for monitored exercise, and these programs are
required to provide patient education and are thus excellent
resources for multidisciplinary risk-factor care.
Two important misconceptions held by many CV experts
are, first, the feeling that they lack the skill to deliver
effective counseling about behavior modification (such as
smoking cessation or weight loss) and other lifestyle changes
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(30) and, second, that the elderly may not benefit as much
as the young when prescribed preventive interventions (such
as drug treatment for isolated systolic hypertension). These
misconceptions lead to undertreatment or, at worst, with-
holding of preventive counseling or therapies known to
prolong life and reduce mortality. In fact, these misconcep-
tions have been dispelled by recent epidemiological data and
randomized, placebo-controlled trials (31,32). Greenlund et
al. (31) showed that in 52,046 persons in 20 states partici-
pating in the 1999 Behavioral Risk Factor Surveillance
System, the proportion of persons who were engaged in
dietary changes was higher among those who received
physician advice (85.4%) than among those who did not
receive such advice (56.0%). In this same population, the
percentage engaged in exercise was greater among those
who received physician advice (76.5%) to exercise than
among those who did not receive such advice (38.5%).
Regarding the relative value of preventive therapies achieved
by elderly persons, Hunt et al. (32) recently showed that in
patients who are 65 years or older with a history of coronary
heart disease and only average or moderately elevated
cholesterol levels, pravastatin treatment resulted in a signif-
icantly greater benefit (reductions in death or major CV event)
than in younger patients. Furthermore, data from the Systolic
Hypertension in the Elderly Program and Long-term Inter-
vention with Pravastatin Ischemic Disease trials demonstrate
the gaps in overall risk-reduction experienced when only single
risk factors are treated, emphasizing the role of CV specialists
and multidisciplinary teams in global risk management.
Current gaps and missed opportunities. Several studies
document important missed opportunities in all settings of
patient encounters (24,33–36). In the in-patient arena, the
admitting clinical history, review of systems, and past
medical history often fail to elicit the presence of coronary
risk factors. Frolkis et al. (37) showed that even among the
best performing physicians, the rate of screening for estab-
lished major coronary risk factors in patients admitted to a
coronary care unit were 89%, 74%, 68%, 59%, 56%, 37%,
and only 11% for the presence of cigarette use, known
coronary heart disease, hypertension, hyperlipidemia, family
history, diabetes, and postmenopausal status, respectively.
Similarly, abnormalities or clues on physical examination
(such as elevated blood pressure (BP), widened pulse pres-
sure, xanthelasma, and so forth) and on the routine blood
tests and electrocardiogram (such as left ventricular hyper-
trophy) unrelated to the chief complaint may not trigger the
appropriate preventive intervention. In fact, at the time of
discharge after a myocardial infarction (MI), most patients
do not receive appropriate advice and counseling about
coronary risk factors and secondary prevention (38). In
addition, prescriptions for aspirin, beta-blockers, and lipid-
lowering agents that are known to reduce recurrent infarc-
tion and CV complications remain suboptimal (34,39).
The gaps in effective delivery of preventive services noted
in the in-patient setting are similarly seen in patient
encounters in the out-patient and diagnostic laboratory
settings. For example, analysis of the National Ambulatory
Medical Care Survey data about preventive health behaviors
during office visits demonstrated that a high proportion of
office visits in 1995 did not include counseling for the
prevention of CVD (35). Berlowitz et al. (40) showed that
increases in therapy occurred in only 6.7% of visits despite
an average of more than six hypertension-related visits per
year in a group of 800 male veterans (40% of whom had a
BP greater than or equal to 160/90 mm Hg) during a
two-year period. Current smokers may not receive counsel-
ing or advice to quit smoking during any number of visits to
the clinic, and praise or encouragement is rarely given when
patients achieve mild success in lifestyle changes. Many
hospitals do not have a structured smoking-cessation pro-
gram or medical director responsible for coordinating global
CV preventive services. Luzier et al. (41) recently showed
that even in the presence of compelling laboratory data
(such as left ventricular ejection fraction less than 40% in
post-infarction patients) as many as 46% of eligible patients
are discharged without a prescription for an angiotensin-
converting enzyme inhibitor. Of the patients who received
the drug, only 11% received the recommended dosages (41).
The role of medical informatics in improving preventive
services. Although lack of adequate training and limited
skills are often cited as reasons for the observed gaps in the
delivery of quality preventive services (42,43) CME alone is
unlikely to change practice patterns unless it is coupled with
chart audits and constructive feedback to specialists when
deviations from guideline recommendations are noted.
Most importantly, reliance on the busy specialists to re-
member all guidelines for all CV diagnoses during all
patient encounters is unrealistic. A recent review of the
National Guidelines Clearing House Website showed a
total of 119 published guidelines intended for physicians on
CVD alone (44). The use of evidence-based prompts, alerts,
and reminders can help improve physician compliance with
guidelines for preventive care (45–47).
Gaps in the delivery of preventive services and limited
compliance with established guidelines by CV and hyper-
tension specialists are more reflective of health care systems
issues, forgetfulness, and limited time during the patient
encounter than of deficiencies in the specialists’ knowledge
(48). This contrasts with what has been published for
internists regarding diagnostic testing in preventive services
(use of electrocardiograms, cholesterol level tests, and chest
radiographs) and behavioral counseling to promote health
(in the areas of smoking cessation and physical activity).
Schwartz et al. (49) concluded that internists used effective
preventive interventions less frequently and ineffective prac-
tices more frequently than experts recommend and that this
observation was associated with habit, attitude, and a lack of
adequate knowledge. In addition to providing continuing
education, even greater emphasis must be placed on health
care systems changes and informatics supports that will
enable of guideline-based electronic prompts and reminders
to be implemented at each patient encounter. Notably, a
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number of informative tools are available to assist with
global risk assessment (see Appendix: Resource Guide).
These changes at the health care system level will represent
an important safety net for CVD prevention for all patients.
Important barriers and templates for improvement. The
key barriers to the successful delivery of preventive services
include the lack of effective communication between CV
specialists and referring primary care physicians, decreasing
the length of time the CV specialist spends with the patient,
the inadequate reimbursement for preventive services, inad-
equate medical informatics support, and other health care
system barriers.
Templates for improvement must focus on the building
of partnerships and improved communication among and
between CV and hypertension specialists, referring primary
care physicians, and non-physician providers. As Turner
and Ball (50) stated 25 years ago:
“Cardiologists on their own are unlikely to succeed in a
program of prevention. They need the help of many others,
including community nurses, nutritionists, public health
workers, sociologists, and of course general practitioners,
but they have responsibility for leadership and for providing
background knowledge.”
Investments must be made in improving informatics
support and development of guideline-based electronic
prompts, alerts, and reminders to facilitate the delivery of
preventive care services.
CAN CV SPECIALISTS BE
CHAMPIONS OF PREVENTION?
Cardiovascular specialists shoulder a broad range of respon-
sibilities for the care of individuals with CVD or the
potential for developing it. They also bear responsibility for
the CV health of communities, specifically by acting at the
political level to encourage and assist in the implementation
of healthy lifestyle changes, for example, through promotion
of sidewalks for walking, parks for recreation, and healthier
food in schools. For individual patients, through educational
and other efforts, CV specialists are expected to contribute
significantly to both the treatment and prevention of CVD.
There is no question that, among other duties and
responsibilities, CV specialists should serve as champions of
prevention. For example, in the recent ACC COCATS
document on Training in Preventive Cardiovascular Med-
icine (12), in the Cardiac Rehabilitation guidelines of the
American Heart Association (AHA)/American Association
of Cardiovascular and Pulmonary Rehabilitation (51), and
in such documents as the AHA Primary and AHA/ACC
Secondary Prevention Guidelines (52,53), cardiologists are
designated as being responsible for delivering preventive
care to their patients. As a further specific example, in a
recent AHA statement on when to start cholesterol-
lowering treatment after a MI (54), the following appeared:
“The cardiovascular specialist or attending physician
should be responsible for starting some form of cholesterol-
lowering therapy in patients upon discharge from the
hospital after acute coronary events. Failure to do so can
convey a message to the patient’s follow-up physician that
cholesterol management is not necessary. The cardiovascu-
lar specialist thus should ensure that appropriate therapy is
initiated and maintained. Interaction between the cardio-
vascular specialist and primary care physician will further
assure that cholesterol management is initiated and contin-
ued and that the patient is monitored for drug toxicity.”
There are many other examples in the recent cardiology
literature affirming that prevention of CVD or prevention of
recurrent disease in cardiac patients (secondary prevention)
is directly within the role of CV specialists.
In many clinical settings, prevention of CVD is a multi-
disciplinary responsibility, and this division of labor can be
both a help and a hindrance to the delivery of CV preventive
services. For example, in the delivery of services for cardiac
rehabilitation, smoking cessation, exercise therapy, dietary
therapy, weight control, and hypertension control programs,
CV specialists are typically members of a team of therapists
rather than solo practitioners. Moreover, for many of these
services, a patient may view a primary care physician as the
most responsible physician, rather than the consulting CV
specialist. Nonetheless, as suggested by the quotation above
concerning the delivery of cholesterol-lowering therapy after
MI, communication between practitioners and the delivery
of a clear, consistent message is crucially important. Coor-
dination of efforts is also important, and although the CV
specialist may not have exclusive (or even primary) respon-
sibility for the delivery of preventive services, it is imperative
that CV specialists convey to patients the importance of the
effort and secure the necessary care within the local health
care system.
In some cases, the cardiologist will be the leader of the
team (e.g., Head of the Cardiac Rehabilitation Program),
but in many clinical settings, the CV specialist may be
uninvolved in the direct delivery of the services (e.g., most
smoking cessation programs). Whether as team leader, team
member, or referral source, it is extremely important for a
CV specialist to collaborate with other professionals when
this is in the best interest of the patient. Specialists may
need to draw on the complementary skills and knowledge of
nurses, pharmacists, dietitians, optometrists, dentists and
physician assistants. Cardiovascular specialists also need to
learn when to utilize other specialists by appropriately referring
patients for more intensive counseling. Minimally, CV special-
ists should be expected to perform the “Four As” of preventive
care developed in the treatment of smoking cessation (55):
Assess the need for the preventive service.
Advise the patient to seek preventive services or to modify
behavior as indicated.
Assist the patient in the provision of preventive treat-
ments (as needed).
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Arrange for follow-up of the patient to reinforce positive
changes and to redirect behavior as needed.
A number of barriers inhibit the delivery of preventive
services in clinical medicine (56). One of the barriers most
commonly cited is “lack of time” to provide personal delivery
of the preventive service, whether it is smoking cessation,
dietary counseling, or other aspects of the comprehensive
approach to preventing CVD (57,58). As several authorities
in the field of prevention have designated, lack of time is
most often an excuse, not a real barrier. There are a variety
of systems (59) and other assistance devices to allow busy
clinicians to promote the practice and delivery of services in
preventive cardiology (60). If the clinicians are properly
organized and committed, they can have “time” to succeed
and deliver preventive services. Successful approaches to
the delivery of CV preventive services have been reported
(59,61,62), and most of these require primarily that CV
specialists focus on prevention for only a few minutes
with the patient. Success often requires development of a
multidisciplinary approach (63) built on a strong com-
mitment to the best possible preventive service that can
be offered.
Although preventive services are distinctly within the
purview of CV specialists and many successful programs are
available, evidence shows that referrals to these programs
and participation in these programs are sub-optimal (63,64).
Problems with optimal participation in such programs
involve patient factors, physician factors, and system factors.
Reviews have suggested ways of addressing each of these
problem areas.
In conclusion, CV specialists should indeed be champi-
ons of prevention. There are useful examples in the litera-
ture to guide even the busiest specialists, including those in
private practice (20,65–67) to meet this challenge. In
addition to the role of CV specialists as champions for their
own patients, CV specialists possess distinctive knowledge
and skills that should be shared with other physicians
through preventive cardiology educational sessions, promo-
tion of optimal practice patterns, and leadership in local
preventive cardiology practices. The CV specialist is “the
expert” on prevention of CVD and typically possesses
superior knowledge about the most up-to-date preventive
strategies available (68,69). It is logical—and appropriate—
for specialists to share this knowledge more widely with
colleagues and to champion the broader adoption of
evidence-based preventive and CV rehabilitation services in
the community.
WHAT IS THE ROLE OF
ACADEMIC PREVENTIVE CV SPECIALISTS?
What is the role of academic preventive CV specialists?
Is there a need for subspecialty preventive cardiologists?
With the burden of CV illness increasing by 30% to 40%
over the next 20 years and with over two million cases of
heart failure in America today, the need for a preventive
academically oriented CV specialist has never been greater
(70,71). In addition, patients are not meeting National
Cholesterol Education Program targets for low-density
lipoprotein cholesterol, many patients do not meet the Sixth
Report Joint National Committee VI on Prevention, De-
tection, Evaluation, and Treatment of High Blood Pressure
(JNC VI) targets for BP control, and over five million
Americans are likely to have insulin resistance syndrome,
the precursor to full-blown diabetes. Addressing this need
will most certainly improve the care delivered by a variety of
physician specialties and allied health care professionals, but
the need for a preventive academically oriented CV special-
ist has never been greater.
With current CV training focused primarily on subspe-
cialization in either interventional/electrophysiologic cardi-
ology or noninvasive imaging cardiology, there are very few
CV specialists focusing on the ever-increasing challenge of
prevention. Although generalists may have some under-
standing of this field, the complex interplay of lipid disor-
ders, hypertension, and type II diabetes makes preventive
cardiology a subspecialty of its own (27). Furthermore, there
is a progressive increase in the complexity of risk assessment
(genetics, novel risk factors, testing strategies, and so forth)
and in the range of interventions (e.g., drugs). Finally, there
is evolving evidence that CV specialists perform better in
these tasks than generalists (72). Therefore, there is a clear
role for the academic CV preventive specialists and a need to
promote such a subspecialty. A model to consider is the
academic CV specialist defining the field and contributing
to research in prevention while co-participating in the
delivery of preventive services with the primary care physi-
cian and allied health professionals.
What role should preventive CV specialists play in the
division of cardiology? Preventive CV specialists should
not only provide consultation to the primary care physician,
when required, but should also provide expertise to col-
leagues in the division of cardiology through subspecialty
consultation for refractory patients (as done by other inter-
nal consultations such as electrophysiology, heart transplan-
tation, and the like). Preventive CV specialists should also
develop educational initiatives and leadership in outcomes-
oriented research. A preventive cardiology clinic is vital for
supporting clinical activities and should involve colleagues
from other subspecialties (e.g., nephrology, diabetology)
and allied health professionals (e.g., dieticians, social work-
ers). This preventive cardiology program would serve as the
foundation for educating medical students, house officers,
and fellows in the comprehensive diagnosis and manage-
ment of CV risk (16).
Is academic achievement more difficult in prevention?
Many large scale randomized trials and large cohort studies
have been led by academic preventive CV specialists. These
trials, including the Scandinavian Simvastatin Survival Sur-
vey and Heart Outcomes Prevention Education have had a
significant impact on public health. In the future, preventive
cardiologists, who have a unique understanding of the
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research questions before them, should lead these research
initiatives. There is no question that the field of academic
preventive CV is evolving. Academic recognition is dispro-
portionately higher for basic and translational research than
for outcomes research (seen as less cutting-edge). Inade-
quate funding for preventive cardiology is a significant
barrier to academic achievement, and a lack of funding often
leads to dependence on the pharmaceutical industry for
support. Funding must be increased to a level of parity with
other CV research if this subspecialty is to survive. As an
epidemic of CVD evolves, measures to reward and recog-
nize excellence in academic/preventive research in cardiol-
ogy, and education must be undertaken in order to recruit
young investigators to this field (73).
Are there enough preventive CV specialists? Relative to
the increasing burden of CV illness, there is a significant
shortage of academic preventive CV specialists, primarily
because of the relatively small number of training programs
available to cardiology fellows with specific preventive sub-
specialty training. For those universities with training pro-
grams, there are no clear standards for subspecialty qualifica-
tion. Fortunately, the updated COCATS will provide an
overview of Level III training that is focused on academic
preventive CV specialists (12). As outlined in COCATS, it is
anticipated that each academic program should have at least
one or two full-time academic preventive CV specialists to
meet the needs as outlined. Reinstitution of effective training
programs such as the NHLBI-sponsored Preventive Cardiol-
ogy Academic Awards, which did much to supply the currently
trained academic preventive cardiologists should be considered.
How might the academic CV preventive specialist help
foster an effective partnership between the CV field and
public health? Because CV prevention is a multidisci-
plinary endeavor, public health outcomes research needs to
be directed by experts knowledgeable in the complex
interactions of the various factors. Educational initiatives
for the public at large, patients at high risk, and the
medical community as a whole must be championed by those
with the highest level of expertise. Comprehensive national
faculty development workshops that focus principally on in-
structional development have been found effective in achieving
a broad range of educational initiatives guided toward the
specialists and toward the public (74).
The preventive CV specialist would ideally have formal
clinical training as well as a Masters degree in public health
or similar expertise in outcomes research. Such a specialist
would serve as a natural bridge between public health issues
and the way those issues affect frontline cardiology. The
medical and the public health community are in constant
need of education and feedback in the management of
conventional CV risk factors. This would be a natural role
for the academic preventive CV specialist and could con-
ceivably lead to better adherence to national guidelines and
evidence-based medicine.
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